(Q35981837)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690022%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

title

Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690022%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690022%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

author name string

S Lakhani

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690022%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

P Selby

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690022%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

J M Bliss

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690022%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

M E Gore

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690022%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

T J McElwain

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690022%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

language of work or name

English

0 references

publication date

1 February 1990

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690022%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 September 2019

http://eprints.whiterose.ac.uk/100586/

content deliverer

White Rose Research Online

copyright license

Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported

0 references

published in

British Journal of Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690022%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

volume

61

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690022%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

page(s)

330-334

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690022%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690022%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/bjc.1990.65

16 September 2019

exact match

0 references

cites work

Vindesine in patients with metastatic malignant melanoma: a Southwest Oncology Group study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971420

Treatment of advanced malignant melanoma with high-dose melphalan and autologous bone marrow transplantation.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971420

DTIC, CCNU, bleomycin and vincristine (BOLD) in metastatic melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971420

Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971420

High dose BCNU chemotherapy with autologous bone marrow transplantation and full dose radiotherapy for grade IV astrocytoma.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971420

Vindesine as a single agent in the treatment of advanced malignant melanoma

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971420

Neuropsychologic function in children with brain tumors: II. Serial studies of intellect and time after treatment.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1971420

Bleomycin, vincristine, lomustine, and DTIC chemotherapy for metastatic melanoma

24 September 2018

1 reference

12 December 2020

Lomustine, bleomycin, and cisplatin in patients with metastatic malignant melanoma

1 reference

12 December 2020

The use of BELD combination chemotherapy (bleomycin, vindesine, CCNU, and DTIC) in advanced malignant melanoma

1 reference

12 December 2020

The usefulness of analysis of survival by tumor response

1 reference

12 December 2020

PALA, vindesine, and cisplatin combination chemotherapy in advanced malignant melanoma. A pilot study

1 reference

12 December 2020

Re-evaluation of the combination of CCNU, vincristine, and bleomycin in the treatment of malignant disseminated melanoma

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1990.65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690022%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

16 September 2019

CORE ID

15117290

0 references

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1690022%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference